BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS)

Historical Holders from Q2 2014 to Q3 2025

Symbol: BLFS on Nasdaq
Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 48,041,653
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 48,107,711
Holdings value: $1,227,205,552
% of all portfolios: 0%
Number of holders: 188
Number of buys: 92
Number of sells: -91
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Casdin Capital, LLC	12.4%	-11%	$151,967,279	-$19,132,500	5,957,165	-11%	Casdin Capital, LLC	15 Oct 2025
T. Rowe Price Investment Management, Inc.	8.9%		$96,485,160		4,246,706		T. Rowe Price Investment Management, Inc.	30 Jun 2025

Institutional Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	48,107,711	$1,227,205,552	-$40,341,783		$321,426	$25.51	188
2025 Q2	49,891,551	$1,074,666,783	+$46,085,035	$0	$0	$21.54	193
2025 Q1	47,668,681	$1,088,709,499	+$20,128,588	$4,166,016	$57,100	$22.84	188
2024 Q4	46,805,050	$1,214,970,700	+$32,660,204	$122,012	$111,628	$25.96	179
2024 Q3	45,256,383	$1,133,546,998	-$37,704,401	$100,160	$205,328	$25.04	193
2024 Q2	46,759,086	$1,001,701,609	+$52,199,509	$17,144	$248,588	$21.43	164
2024 Q1	44,406,426	$823,506,297	-$18,755,552	$339,465	$3,847,270	$18.55	148
2023 Q4	45,388,256	$737,705,671	+$37,803,026	$518,375	$3,683,875	$16.25	138
2023 Q3	43,572,418	$601,804,361	+$31,718,369	$24,858	$247,199	$13.81	152
2023 Q2	40,574,468	$896,734,819	+$40,556,636	$1,376,830	$192,270	$22.1	155
2023 Q1	38,757,969	$842,823,822	+$17,191,226	$34,800	$411,075	$21.75	165
2022 Q4	38,161,776	$694,539,798	-$10,679,652	$72,800	$882,700	$18.2	160
2022 Q3	38,421,067	$874,137,954	+$38,798,900	$740,000	$537,000	$22.75	169
2022 Q2	36,797,091	$508,323,451	+$12,324,863	$478,000	$6,000	$13.81	146
2022 Q1	35,131,386	$798,491,817	-$7,596,956	$1,111,000	$164,000	$22.73	155
2021 Q4	34,958,126	$1,302,914,183	+$115,722,970	$3,768,000	$1,979,000	$37.27	165
2021 Q3	31,670,115	$1,340,574,104	+$157,430,709	$1,198,000	$2,565,000	$42.32	159
2021 Q2	27,974,612	$1,245,139,856	+$121,193,958	$1,014,000	$4,819,000	$44.51	130
2021 Q1	25,413,123	$914,855,472	+$45,084,655	$2,560,000	$5,758,000	$36	130
2020 Q4	24,231,900	$966,664,009	+$97,438,296	$2,103,000	$3,987,000	$39.89	125
2020 Q3	22,145,073	$640,866,936	+$216,554,424	$226,000	$1,247,000	$28.94	104
2020 Q2	14,927,170	$244,144,153	+$49,280,131	$0	$197,000	$16.35	82
2020 Q1	12,125,864	$115,194,176	+$10,152,917	$191,000	$0	$9.5	73
2019 Q4	10,352,922	$167,504,873	-$1,157,792	$435,000	$173,000	$16.18	79
2019 Q3	10,248,020	$170,376,845	+$21,192,749	$441,000		$16.63	78
2019 Q2	8,980,039	$150,448,121	+$6,076,613			$16.95	71
2019 Q1	8,599,553	$153,847,483	+$19,590,648			$17.89	65
2018 Q4	7,525,099	$90,520,000	-$6,348,673			$12.03	52
2018 Q3	7,614,985	$133,259,000	+$55,383,982			$17.5	51
2018 Q2	4,545,796	$51,865,700	+$32,049,888			$11.41	45
2018 Q1	1,683,075	$8,619,000	-$151,371			$5.12	23
2017 Q4	1,709,367	$10,256,000	+$2,569,633			$6	26
2017 Q3	1,282,103	$7,324,000	+$5,380,776			$5.71	19
2017 Q2	339,958	$813,000	+$183,536			$2.4	8
2017 Q1	266,914	$557,000	+$91,186			$2.09	8
2016 Q4	266,829	$431,000	-$33,995			$1.6	11
2016 Q3	282,237	$518,000	-$124,588			$1.84	10
2016 Q2	381,436	$609,000	+$39,267			$1.6	9
2016 Q1	356,480	$653,000	+$28,574			$1.83	9
2015 Q4	338,498	$736,000	+$10,054			$2.2	7
2015 Q3	333,970	$707,000	+$93,511			$2.12	6
2015 Q2	290,217	$566,010	-$196,456			$1.95	5
2015 Q1	422,277	$681,008	-$329,999			$1.61	9
2014 Q4	623,246	$1,023,008	-$91,795			$1.64	7
2014 Q3	579,026	$1,216,311	+$668			$2.1	7
2014 Q2	577,808	$1,318,011	+$1,318,011			$2.28	8